June 2025: Biobeat’s Next-Generation Wearable Solution

AI-powered wearable for continuous, cuffless vital sign monitoring in clinical and home settings.

Image credits: Biobeat

In a groundbreaking leap for remote patient monitoring and hospital care, Biobeat has introduced its state-of-the-art wearable biosensor – a cuffless, wireless solution that redefines how vital signs are continuously measured and managed across healthcare settings.

This lightweight, sticker-like device is seamlessly applied to the upper torso or wrist and leverages advanced PPG (photoplethysmography) and AI-powered analytics to deliver continuous, real-time measurements of critical parameters such as blood pressure, heart rate, respiratory rate, blood oxygen saturation (SpO₂), cardiac output, and stroke volume – all without the need for invasive procedures or bulky equipment.

Built with hospital-grade precision and designed for maximum patient comfort, Biobeat’s wearable biosensors empower clinicians with automated, real-time data that improves decision-making and dramatically reduces the need for manual measurement. The device wirelessly transmits data to a secure cloud-based platform, where AI-driven dashboards present trends and alerts in a highly intuitive interface, transforming reactive care into proactive, personalised healthcare.

From hospitals to home settings, this FDA-cleared and CE-marked technology allows for early detection of clinical deterioration, reduced hospital readmissions, and more efficient remote patient management, especially for individuals with chronic cardiovascular or pulmonary conditions.

“We are proud to offer a truly wearable, intelligent solution that changes how vital signs are monitored,” said a Biobeat representative. “By eliminating the cords, cuffs, and guesswork, our technology ensures that patients receive timely, precise care - whether they’re in a hospital bed or recovering at home.”

About Biobeat
Founded in Israel, Biobeat is a digital health company revolutionising the field of continuous patient monitoring. With a mission to bring hospital-grade accuracy to wearable medical devices, Biobeat integrates AI, cloud computing, and non-invasive sensing into a robust platform that supports clinicians and improves patient outcomes. The company’s solutions are used in hospitals, post-acute care, and home monitoring programs across the globe, demonstrating the power of real-time health insights to save lives and optimise care.

Sam Draper
June 4, 2025

June 2025

Innovation of the Month

Do you want to discover more, visit the website
Visit Website

Other news

Synchron Raises $75M Series C Round

The company announced it has raised C funding led by ARCH Venture Partners, Gates Frontier, et al.

BIOTRONIK Wins FDA Clearance for its Vital Data Sensor in BIOMONITOR IIIm ICM

German biomedical company BIOTRONIK has won FDA clearance for the Vital Data Sensor, a body temp...

AT&T Certifies Telit ME910C1-WW as the Module for its Recently Launched NB-IoT Network

ME910C1-WW is the first module certified by AT&T for its recently launched Narrowband IoT network.

Empatica’s Embrace Plus Smartwatch Will Monitor Health of Astronauts Aboard Mars Mission

Empatica, an MIT Media Lab Spin off that develops medical wearables using AI...
Discover more